Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000970696 | SCV001118289 | benign | not provided | 2019-12-31 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002503067 | SCV002804520 | likely benign | Giant axonal neuropathy 2 | 2022-02-14 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000970696 | SCV005285218 | benign | not provided | criteria provided, single submitter | not provided | ||
Prevention |
RCV003972900 | SCV004789874 | benign | DCAF8-related disorder | 2019-03-12 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |